There are currently 18 active clinical trials seeking participants for Dry Eye research studies. The states with the highest number of trials for Autism participants are California, Florida, Massachusetts and Tennessee.
Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance
Recruiting
Single site, prospective, double-masked, randomized-controlled, two-arm study of the dry eye symptoms as well as corneal and conjunctival staining in subjects using 2 different eyedrops. Subjects will be assessed at a screening visit, and 2 follow-up visits. Clinical evaluations will include patient questionnaire, tear-breakup time, and slit lamp exam.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/11/2024
Locations: Scripps Poway Eyecare & Optometry, San Diego, California
Conditions: Dry Eye
Open-Label, Multicenter, Phase 4 Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
Recruiting
An Open-Label, Multicenter, Phase 4 Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
Gender:
All
Ages:
18 years and above
Trial Updated:
03/07/2024
Locations: Site 205, Petaluma, California +4 locations
Conditions: Dry Eye
A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
Recruiting
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/05/2024
Locations: Vanda Investigational Site, Andover, Massachusetts
Conditions: Dry Eye
Feasibility of Dynamic Muscle Stimulation + Radiofrequency for Improving Blink Quality in Subjects With Dry Eye Disease
Recruiting
To demonstrate that DMSt + RF improves eye blink quality in subjects with dry eye disease
Gender:
All
Ages:
22 years and above
Trial Updated:
01/21/2024
Locations: Manhattan Face and Eye Cosmetic and Orbital Surgery, New York, New York
Conditions: Eyelid Diseases, Eyelid Movement Disorders, Dry Eye, Dry Eye Syndromes, Skin Laxity
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
Recruiting
This is a single site, prospective, cross-sectional, controlled clinical study on a total of 66 subjects. The subjects are divided into two groups: Hypertonic Saline Non-Responders (33 subjects) and Hypertonic Saline Responders (33 subjects). After completion of questionnaires, the subjects will undergo Dry Eye Disease testing and functional nerve testing. Subjects who qualify will be dispensed 4 weeks of preservative free artificial tears and instructed to instill one drop into each eye twice d... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/19/2024
Locations: Tufts Medical Center-New England Eye Center, Boston, Massachusetts
Conditions: Dry Eye
Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers
Recruiting
Miebo (Perfluorohexyloctane) is a novel, non-aqueous, single entity, preservative free, ophthalmic drop. This drop was recently approved by the Food and Drug Administration (FDA) for the treatment of Meibomian Gland Disease (MGD). All published data on Miebo has been done in non-contact lens wearers. As contact lens dropout rates seem to be an ongoing problem for practitioners, we are performing this study utilizing this novel new drug with contact lens patients to determine if the drops assist... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/21/2023
Locations: Gordon Schanzlin New Vision Institute, San Diego, California
Conditions: Dry Eye, Dry Eye, Evaporative, Dry Eye Disease, Evaporative Dry Eye, Evaporative Dry Eye Disease, Kerato Conjunctivitis Sicca
Evaluating Impact of Systane iLux on Dryness Symptoms and Wearing Time in Contact Lens Users
Recruiting
To evaluate dry eye symptoms and contact lens wearing times after a single iLux treatment by evaluating change from baseline in OSDI scores, subjective CLDEQ8 and CL wearing time questionnaires, and meibomian gland secretion scores.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/14/2023
Locations: Periman Eye Institute, Seattle, Washington
Conditions: Meibomian Gland Dysfunction, Dry Eye
Effects of Supplementation With PUFAs and Antioxidants for Contact Lens Discomfort
Recruiting
HydroEye® is a dietary supplement that contains both EPA and DHA, as well as GLA and ALA in the form of black currant seed oil. It also has vitamins A, E, C, B6, and magnesium, many of which are involved in fatty acid metabolism. In 2013, Sheppard et al. tested HydroEye® in dry eye patients who were not contact lens wearers and found that symptoms and corneal smoothness improved in response to HydroEye® supplementation. To date, HydroEye® has not been assessed in patients with contact lens disco... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
08/16/2023
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Dry Eye, Contact Lens Complication
Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia
Recruiting
Safety and Efficacy of Medications for Migraine in Patients with Dry Eye Disease or Asthenopia
Gender:
All
Ages:
18 years and above
Trial Updated:
06/21/2023
Locations: NVision-EWEI-Torrance, Torrance, California
Conditions: Dry Eye, Asthenopia
Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED)
Recruiting
This prospective, single-center, randomized, double-masked, parallel comparison, sponsored study seeks to investigate the efficacy of Intracanalicular dexamethasone Insert (IDI) on ameliorating the signs and symptoms of dry eye disease.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/11/2023
Locations: Tufts Medical Center, Boston, Massachusetts
Conditions: Dry Eye
CEQUA for Sjogren's Syndrome Dry Eye
Recruiting
The primary objective of this study is to show that CEQUA (cyclosporine 0.09% ophthalmic solution) improves symptoms of dry eye disease in a population of patients with Sjogren's Syndrome diagnosis.
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
02/08/2023
Locations: Center for Ophthalmic and Vision Recearch, Manhattan, New York
Conditions: Dry Eye, Dry Eye Syndromes, Sjogren's Syndrome
Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days
Recruiting
This study will be a randomized, double-blind prospective in 3 clinical sites to compare the efficacy of two currently approved topical ophthalmic drops in the clearing central corneal staining in 90 days prior to elective cataract or LASIK surgery.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
10/18/2022
Locations: Toyos Clinic, Nashville, Tennessee
Conditions: Dry Eye